Analysts’ Updated EPS Estimates for January 8th (ACCD, BMO, CM, CPNG, EQT, FLUT, HLN, HOVR, IQ, L)

Analysts’ updated eps estimates for Wednesday, January 8th:

Accolade (NASDAQ:ACCD) had its hold rating reiterated by analysts at Needham & Company LLC.

Accolade (NASDAQ:ACCD) had its hold rating reissued by analysts at Canaccord Genuity Group Inc..

Bank of Montreal (TSE:BMO) (NYSE:BMO) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. Royal Bank of Canada currently has C$161.00 target price on the stock, up from their previous target price of C$133.00.

Canadian Imperial Bank of Commerce (TSE:CM) (NYSE:CM) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. Royal Bank of Canada currently has C$103.00 target price on the stock, up from their previous target price of C$97.00.

Coupang (NYSE:CPNG) had its target price cut by Citigroup Inc. from $31.00 to $28.00. The firm currently has a buy rating on the stock.

EQT (NYSE:EQT) had its price target boosted by Wells Fargo & Company from $52.00 to $53.00. Wells Fargo & Company currently has an overweight rating on the stock.

Flutter Entertainment (NYSE:FLUT) had its target price reduced by Wells Fargo & Company from $300.00 to $285.00. The firm currently has an overweight rating on the stock.

Haleon (NYSE:HLN) was downgraded by analysts at Sanford C. Bernstein from an outperform rating to a market perform rating.

New Horizon Aircraft (NASDAQ:HOVR) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $2.00 price target on the stock.

iQIYI (NASDAQ:IQ) had its negative rating reaffirmed by analysts at OTR Global.

Loblaw Companies (TSE:L) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. The firm currently has C$200.00 price target on the stock.

Medexus Pharmaceuticals (TSE:MDP) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. They currently have C$4.00 price target on the stock.

TransAlta (TSE:TA) (NYSE:TAC) was downgraded by analysts at CIBC from an outperform rating to a neutral rating. CIBC currently has C$23.00 target price on the stock, up from their previous target price of C$17.00.

Verona Pharma (NASDAQ:VRNA) had its target price raised by Wells Fargo & Company from $64.00 to $74.00. Wells Fargo & Company currently has an overweight rating on the stock.

George Weston (TSE:WN) was upgraded by analysts at Scotiabank from a sector perform rating to an outperform rating. Scotiabank currently has C$240.00 price target on the stock, up from their previous price target of C$218.00.